Compare SGP & GFUZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SGP | GFUZ |
|---|---|---|
| Founded | 2019 | N/A |
| Country | United States | United States |
| Employees | 65 | N/A |
| Industry | Medical/Dental Instruments | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 650.9M | 687.0M |
| IPO Year | N/A | 2025 |
| Metric | SGP | GFUZ |
|---|---|---|
| Price | $25.09 | $9.41 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $45.00 | N/A |
| AVG Volume (30 Days) | 97.2K | ★ 316.4K |
| Earning Date | 05-15-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.06 | $6.08 |
| 52 Week High | $30.56 | $11.00 |
| Indicator | SGP | GFUZ |
|---|---|---|
| Relative Strength Index (RSI) | 68.69 | 53.46 |
| Support Level | $20.95 | $8.08 |
| Resistance Level | $25.83 | $10.49 |
| Average True Range (ATR) | 1.34 | 1.29 |
| MACD | 0.38 | 0.11 |
| Stochastic Oscillator | 95.56 | 61.99 |
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.
General Fusion Group Ltd is focused on developing fusion energy technology based on Magnetized Target Fusion (MTF), which combines magnetic confinement and mechanical compression to achieve fusion conditions. It operates a large-scale demonstration system, Lawson Machine 26 (LM26), intended to validate elements of its technology and support the development of commercial fusion power plants for electricity generation.